CoChat

Expression of Kinase-defective Mutants of c-Src in Human Metastatic Colon Cancer Cells Decreases Bcl-xL and Increases Oxaliplatin- and Fas-induced Apoptosis

Open access

The DOI matches its Crossref record; 48 of the 48 references it cites were found in a registry or an index.

Abstract

Tumor resistance to current drugs prevents curative treatment of human colon cancer. A pressing need for effective, tumor-specific chemotherapies exists. The non-receptor-tyrosine kinase c-Src is overexpressed in >70% of human colon cancers and represents a tractable drug target. KM12L4A human metastatic colon cancer cells were stably transfected with two distinct kinase-defective mutants of c-src. Their response to oxaliplatin, to SN38, the active metabolite of irinotecan (drugs active in colon cancer), and to activation of the death receptor Fas was compared with vector control cells in terms of cell cycle arrest and apoptosis. Both kinase-defective forms of c-Src co-sensitized cells to apoptosis induced by oxaliplatin and Fas activation but not by SN38. Cells harboring kinase-defective forms of c-Src carrying function blocking point mutations in SH3 or SH2 domains were similarly sensitive to oxaliplatin, suggesting that reduction in kinase activity and not a Src SH2-SH3 scaffold function was responsible for the observed altered sensitivity. Oxaliplatin-induced apoptosis, potentiated by kinase-defective c-Src mutants, was dependent on activation of caspase 8 and associated with Bid cleavage. Each of the stable cell lines in which kinase-defective mutants of c-Src were expressed had reduced levels of Bcl-x(L.) However, inhibition of c-Src kinase activity by PP2 in vector control cells did not alter the oxaliplatin response over 72 h nor did it reduce Bcl-x(L) levels. The data suggest that longer term suppression of Src kinase activity may be required to lower Bcl-x(L) levels and sensitize colon cancer cells to oxaliplatin-induced apoptosis.

Overview

Integrity signals

Registry

Crossref · 10.1074/jbc.m408550200

Cites

48 of 48 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Research works printed but not linked: 7

  1. Frame, 2002, Biochim. Biophys. Acta, 1602, 114
  2. Cam, 2001, Cancer, 92, 61, 10.1002/1097-0142(20010701)92:1<61::aid-cncr1292>3.0.co;2-d · DOI · Paper page
  3. Scudiero, 1988, Cancer Res., 48, 4827
  4. Kinoshita, 2000, Int. J. Cancer, 88, 986, 10.1002/1097-0215(20001215)88:6<986::aid-ijc23>3.0.co;2-b · DOI · Paper page
  5. Tillman, 1999, Clin. Cancer Res., 5, 425
  6. Morikawa, 1988, Cancer Res., 48, 1943
  7. Masumoto, 1999, Int. J. Cancer, 80, 731, 10.1002/(sici)1097-0215(19990301)80:5<731::aid-ijc17>3.0.co;2-h · doi:10.1002/(sici)1097-0215(19990301)80:5<731::aid-ijc17>3.0.co;2-h

Cited by

See all 60

Metadata

Authors
Griffiths, G. J., Koh, M. Y., Brunton, V. G., Cawthorne, C., Reeves, N. A., Greaves, M., Tilby, M. J., Pearson, D. G., Ottley, C. J., Workman, P., Frame, M. C., & Dive, C.
Affiliations
  • Cancer Research UK (GB)
  • Newcastle University (GB)
  • Durham University (GB)
  • Institute of Cancer Research (GB)
  • Cancer Research UK Scotland Institute (GB)
Corresponding author
Dive, Caroline
Venue
Journal of Biological Chemistry
Publisher
Elsevier BV
Published
2004-10
Volume
279
Issue
44
Pages
46113-46121
ISSN
0021-9258 (ISSN-L)
OpenAlex
W2136103100
Cited by
60
References
48
Citations by year
2026: 1 · 2025: 1 · 2024: 1 · 2023: 1 · 2022: 1 · 2021: 2 · 2019: 1 · 2017: 2 · 2016: 2 · 2015: 3 · 2014: 3 · 2013: 4
FWCI
2.25
Type
journal article
Language
en
Open access
Licence
Locations
  • Journal of Biological Chemistry (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • Durham Research Online (Durham University) (acceptedVersion)
  • Durham Research Online (Durham University) (submittedVersion, cc-by)
  • Research Explorer (The University of Manchester) (submittedVersion)
  • Newcastle University ePrints (Newcastle Univesity)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Cell death mechanisms and regulation
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer Mechanisms and Therapy
  • Health Sciences › Medicine › Oncology › Cancer-related Molecular Pathways
Keywords
Src kinase, colon cancer, metastatic colon cancer, oxaliplatin, Fas-mediated apoptosis, Bcl-xL, SN-38, irinotecan, caspase-8, Bid cleavage, apoptosis sensitization, SH2 domain, SH3 domain, PP2, non-receptor tyrosine kinase, drug resistance
MeSH terms
Oxaliplatin, CSK Tyrosine-Protein Kinase, Colonic Neoplasms, Humans, Mutation, Neoplasm Metastasis, Organoplatinum Compounds, Protein-Tyrosine Kinases, Pyrimidines, Apoptosis, fas Receptor, src-Family Kinases, Proto-Oncogene Proteins c-bcl-2, Caspases, Cell Line, Tumor, bcl-X Protein, Caspase 8

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.